Guided Therapeutics (GTHP) Interest Expenses (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly Interest Expenses came in at $136000.0 in Q2 2026, down 13.38% year-over-year from $157000.0 in Q2 2025, and down 9.93% quarter-over-quarter from $151000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Interest Expenses (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Interest Expenses across 17 years of filings, most recently posting $136000.0 for Q2 2026.
- In Q2 2026, Interest Expenses fell 13.38% year-over-year to $136000.0; the TTM figure through Jun 2026 stood at $600000.0 (up 9.89% YoY), while the FY2025 annual figure was $617000.0, up 61.94% from the prior year.
- Interest Expenses came in at $136000.0 for Q2 2026 at Guided Therapeutics, down from $151000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $256000.0 in Q2 2022 to a low of $64000.0 in Q1 2024.
- Average Interest Expenses over 5 years is $119166.7, with a median of $118500.0 recorded in 2024.
- Year-over-year, Interest Expenses plunged 73.91% in 2022 and surged 129.69% in 2025.
- Over 5 years, Interest Expenses stood at $70000.0 in 2022, then advanced by 2.86% to $72000.0 in 2023, then jumped by 86.11% to $134000.0 in 2024, then jumped by 37.31% to $184000.0 in 2025, then decreased by 26.09% to $136000.0 in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $136000.0 in Q2 2026, $151000.0 in Q1 2026, and $184000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | 136,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 184,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 134,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 75,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Jun 30, 2023 | 69,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 155,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 101,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 594,000.00 |